Cost-Benefit Analysis on Health Effects of Contraceptive Methods Elizabeth O’Neill, ECON 539, 4.25.07.

Slides:



Advertisements
Similar presentations
BREAST CANCER SCREENING Anoop Agrawal, M.D.. NEW USPSTF BREAST SCREENING GUIDELINES Published by US Preventative Screening Task Force in November 2009.
Advertisements

Cost-benefit and cost-effectiveness analysis: applications to health care programs and policies Greg Mason PRA Inc. and University of Manitoba October.
Variations In Women’s Knowledge And Attitudes Regarding Preconception Healthcare Peter S. Bernstein, MD, MPH Professor of Clinical Obstetrics & Gynecology.
Socioeconomic differences in the utilisation of health care services: a European overview Anton Kunst for the international seminar on socioeconomic differences.
Chapter 7 Financial Measures. Objectives Define and use financial measures: Revenue Growth Market Share Margin Cost of Quality (COQ) Net Present Value.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Alan M. Garber, M.D., Ph.D. Center for Primary Care and Outcomes Research Center for Health Policy Stanford University VA Palo Alto Health Care System.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older Dana P. Goldman, Federico Girosi et al. American Journal of Public Health November.
Budget Impact Analysis and Return on Investment Usa Chaikledkaew, Ph.D.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
THE PREVENTION OF MOTHER TO CHILD TRANSMISSION of HIV (PMTCT)
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Trends in the.
Cost Effectiveness Analysis To Enhance Mammography Use Dave Alvey Paul Moley.
Does Prevention Pay? HSPM 714 J50. Does Prevention Pay? Pay in what sense? Cost-benefit Cost-effective Cost-saving.
As we wait for class to start, please sign in for today’s attendance tracking: Text to 37607: ERASER netID Go online to AEM 4160 class website Click on.
Knowledge, Cancer Fatalism and Spirituality as Predictors of Breast Cancer Screening Practices for African American and Caucasian Women Staci T. Anderson,
Feasibility of Family Planning Services Inclusion within Public and Private Employers Health Insurance Plans Dr. Mohammed Tarawneh Certified Actuary and.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Personal Finance Risk Management. Net Worth The amount by which assets exceed liabilities. One of the most important calculations one can make. Look for.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 1: Introduction Sept 3, 2008.
Taxes on the Longevity Dividend: Can we Reduce Them? Lessons from the Theoretical Foundations of Medical Cost-Effectiveness Analysis David Meltzer MD,
Pharmacoeconomics & Drug Compliance Dr Arif Hashmi.
Insurance.  Many people in the US are ________ – assume all responsibility for health care costs.  Insurance _______ out of pocket expenses for health.
Health care costs continue to increase! 40% of US citizens are uninsured! Health Insurance 101 (Managed Care)
Pay for Performance – a critical assessment (using recent Estonian experience) “Improving primary care in Europe and the US: Towards patient- centered,
Imarisha Maisha Postpartum family planning for CHWs.
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
Validation / citations. Validation u Expert review of model structure u Expert review of basic code implementation u Reproduce original inputs u Correctly.
انواع ارزيابي های اقتصادي سيدرضا مجدزاده مرکز تحقيقات بهره برداری از دانش سلامت و دانشکده بهداشت دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Make Nutrition Services Count: Cost-Effectiveness Research & Outcomes Research.
Appendices. Appendix 1: Supplementary Data Tables Trends in the Overall Health Care Market.
Flagship Program on Health Sector Reform and Sustainable Financing.
The effects of inadequate preparation quality for colonoscopy Eric Sherer and Michael Catlin August 20 th, 2010 HSR&D Work-in-Progress 1.
Advanced Slide Set, Slide #1 Progestin-Only Injectable Contraceptives Advanced Slide Set.
A Comparison of Fulvestrant 500 mg with Anastrozole as First-line Treatment for Advanced Breast Cancer: Follow-up Analysis from the FIRST Study Robertson.
 Agreed upon fees paid for coverage of medical benefits for a defined benefit period. Premiums can be paid by employers, unions, employees, or shared.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Conceptual Addition of Adherence to a Markov Model In the adherence-naïve model, medication adherence and associated effectiveness assumed to be trial.
Appendices. Appendix 1: Supplementary Data Tables Trends in the Overall Health Care Market.
Cost and Benefits. Introduction Is treatment X worth it?
Changing Clinical Norms: Tobacco Intervention in Pediatric Care Settings Shann Hauck Wyoming Department of Health Substance Abuse Division 2003 National.
1 Cost efficacy of smoking cessation interventions Robert West University College London Logroño, October
Why are the Costs of Medications Increasing and What Can Be Done About It? William H. Shrank, M.D., M.S.H.S. April 15, 2016.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
PSA screening Cost Conscious Project Kristopher Huston January 2016.
Adolescent Contraception
DataBrief: Did you know… DataBrief Series ● September 2011 ● No.18 Differences in Service Utilization by Disability and Residence In 2006, seniors with.
Central American Certificate Course: HIV Monitoring and Evaluation for HIV/AIDS Policy and Program Management BZ ES GT NI PA CR Economic Evaluation and.
Date of download: 6/27/2016 From: Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease: A Cost- Effectiveness Analysis.
T HE I MPACT OF A CUPUNCTURE T REATMENT ON THE U TILIZATION OF O THER H OSPITAL S ERVICES AT AN U RBAN S AFETY -N ET H OSPITAL Ellen Silver Highfield Mckenna.
Chapter 14 Economic Analysis of Clinical and Managerial Interventions Copyright 2015 Health Administration Press.
Department of Public Health Presentation to the Health Cabinet June 14, 2016.
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
The University of Sheffield Extrapolation methods:
Home healthcare – an economic choice for the Health Service?
Rob Vos Director Development Policy and Analysis Division, UN-DESA
HEALTH ECONOMICS BASICS
MOTHER TO CHILD TRANSMISSION of HIV
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
Economic Evaluation of Health Interventions Basic Concepts
Cost Effective Studies
Percent of Total Health Care Spending
Managing Women Living With HIV Infection
Contraception vs. Church
Making the Case: Ending Silos Once and For All with Evidence
Jacqueline E. Darroch, Elizabeth Sully and Ann Biddlecom
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial
Presentation transcript:

Cost-Benefit Analysis on Health Effects of Contraceptive Methods Elizabeth O’Neill, ECON 539,

Central Questions: What are the net health effects and subsequent costs resulting from using various methods of contraception as compared to not using contraception? What are the policy recommendations based on the results? Reference: Sonnenberg, R., Burkman, R., Hagerty, G., Speroff, L., Speroff, T. (2004) Costs and Net Health Effects of Contraceptive Methods. Contraception. 69:

Methods Data source: 1995 National Survey of Family Growth monitoring a 2 yr. period. Sample: Women y.o. who are not attempting to become pregnant during the duration of the study. Causal statement: Thirteen methods of contraception affect various health factors including cancer, cardiovascular, infections and pregnancy but are more effective and less costly than not using a contraceptive.

Units of Analysis Costs were a total $ amount (not disaggregated by private, public or insured costs). Contraceptive methods were expressed in terms of saved quality-adjusted life-years (QALYs). QALY’s are calculated by multiplying each increment of survival by the utility of the increment. Model assumes women will use same method(s) continuously = benefits & cost savings overestimated in the report.

Cost (US $) Marginal cost (US $) Quality-adjusted life-years Marginal quality-adjusted life-years Cost savings vs. number of methods Pregnancies avoided per woman vs. # of methods QALY gains vs. # methods Cost-Benefit Analysis Factors

Summary of Results

Detailed Cost-Utility Results  Least expensive method varies for different time periods: Within 1 year: DMPA (3-month injectable) is the least costly ($5,103 savings) Within 2+ years: Vasectomy is the least costly ($17,300 saved over a 5-year period)  Any contraceptive method used provided substantial healthcare savings and an increase in QALYs.  Methods that require “user intervention less often than daily are the least costly and most effective” (Sonnenberg et al, 2004).

Policy Implications Managed care organizations/health plans should consider providing some contraceptive services as a cost saving measure. Promote DMPA for short-term pregnancy prevention and vasectomies for longer-term prevention through physician and patient education. Further studies needed to determine public/private payment effects on the findings. Questions?